Why Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc (MSTR) Plunged Today
Shares in Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | Director | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | Director | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | Director | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | Large Shareholder, Director | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | Large Shareholder, Director | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.63 | 10,539 | Large Shareholder, Officer, Director | 30,710 | 2024-12-17 | Filing | |
| $32.01 | 68,707 | Large Shareholder, Officer, Director | 41,249 | 2024-12-17 | Filing | |
| $30.35 | 41,667 | Large Shareholder, Officer, Director | 109,956 | 2024-12-16 | Filing | |
| $28.79 | 16,667 | Large Shareholder, Officer, Director | 109,956 | 2024-12-16 | Filing | |
| $28.78 | 17,001 | Large Shareholder, Officer, Director | 109,956 | 2024-12-16 | Filing |
Institutional Investors' Holdings
News See All
Here's How Eli Lily (LLY) Caused Hims & Hers (HIMS) Stock To Fall
Eli Lily continues to dominate the weight loss market, willing to crush any competitor that threatens its dominance.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on La Newsletter de Momentum’s Substack by Mexican Investor. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Hims & Hers Second Quarter 2024 Earnings Conference Call.
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2024 Earnings Call Transcript
Hims & Hers Health, Inc. beats earnings expectations. Reported EPS is $0.04852, expectations were $0.02. Hims & Hers Health, Inc.
15 Best Beauty Stocks To Invest In
In this piece, we will take a look at the 15 best beauty stocks to invest in.
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2023 Earnings Call Transcript
Hims & Hers Health, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.02. Hims & Hers Health, Inc.
14 High Growth Consumer Stocks to Buy
In this article, we will take a look at the 14 high growth consumer stocks to buy.
Billionaire Hedge Funds
